Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions

por Langness, Jacob A, Nguyen, Matthew, Wieland, Amanda, Everson, Gregory T, Kiser, Jennifer J
Publicado 2017

Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study

por Jacobson, Ira M., Poordad, Fred, Firpi-Morell, Roberto, Everson, Gregory T., Verna, Elizabeth C., Bhanja, Sanhita, Hwang, Peggy, Caro, Luzelena, Robertson, Michael, Charles, Edgar D., Platt, Heather
Publicado 2019

Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

por Forns, Xavier, Poordad, Fred, Pedrosa, Marcos, Berenguer, Marina, Wedemeyer, Heiner, Ferenci, Peter, Shiffman, Mitchell L., Fried, Michael W., Lovell, Sandra, Trinh, Roger, Lopez‐Talavera, Juan Carlos, Everson, Gregory
Publicado 2015

309 Quantitative tests (QLFTS) detect impaired hepatic function in a high proportion of chronic hepatitis C patients with fibrosis or compensated cirrhosis and may predict risk of...

por Everson, Gregory T., Kugelmas, Marcelo, DeSantos, Jennifer, Lauriski, Shannon, Shiffman, Mitchell L., Sterling, Richard, Charlotte, Hofmann, Morgan, Timothy, Hoefs, John, Milne, Nora, Rietkerk, William, Wagner, David, Wright, Elizabeth
Publicado 2003

HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape

por Reau, Nancy, Fried, Michael W., Nelson, David R., Brown, Robert S., Everson, Gregory T., Gordon, Stuart C., Jacobson, Ira M., Lim, Joseph K., Pockros, Paul J., Reddy, K. Rajender, Sherman, Kenneth E.
Publicado 2015